Preventing HIV in Injection Drug Users: Choosing the Best Mix of Interventions for the Population
- 1 September 2003
- journal article
- research article
- Published by Springer Nature in Journal of Urban Health
- Vol. 80 (3) , 465-481
- https://doi.org/10.1093/jurban/jtg046
Abstract
Injection drug users (IDUs) transmit the human immunodeficiency virus (HIV) via both needle sharing and sex. This analysis explores the effects of population risk behaviors, intervention effectiveness, intervention costs, and budget and capacity constraints when allocating funds between two prevention programs to maximize effectiveness. The two interventions, methadone maintenance and street outreach, address different types of risk behavior. We developed a model of the spread of HIV and dwided IDUs into susceptible (uninfected) persons and infective persons and separately portrayed sex and injection risk. We simulated the epidemic in San Francisco, California, and New York City for periods from the mid-1980s to the mid-1990s and incorporated the behavioral effects of the two interventions. We used the simulation to find the allocation of a fixed budget to the two interventions that averted the greatest number of infections in the IDUs and their noninjecting sex partners. We assumed that interventions have increasing marginal costs. In the epidemic scenarios, our analysis found that the best allocation nearly always involves spending as much as possible on street outreach. This result is largely insensitive to variations in epidemic scenario, intervention efficacy, and cost. However, the absolute and relative benefits of the best allocation varied. In mid-1990s San Francisco, maximizing spending on outreach averted 3.5% of total HIV infections expected and 10 times the 0.3% from maximizing spending on treatment. In late 1980s New York City, the difference is five-fold (2.6% vs. 0.44%, respectively). Our analyses suggest that, even though prevention works better in higher risk scenarios, the choice of intervention mix is more important in the lower risk scenarios. Models and analyses such as those presented heve may help decision makers adapt individual prevention programs to their own communities and to reallocate resources among programs to reflect the evolution of their own epidemics.Keywords
This publication has 58 references indexed in Scilit:
- Optimal Investment in a Portfolio of HIV Prevention ProgramsMedical Decision Making, 2001
- An Analysis of Optimal Resource Allocation for Prevention of Infection with Human Immunodeficiency Virus (HIV) in Injection Drug Users and Non-UsersMedical Decision Making, 1999
- Effectiveness of HIV/AIDS Interventions on Drug Use and Needle Risk Behaviors for Out-of-Treatment Injection Drug UsersJournal of Psychoactive Drugs, 1998
- Effectiveness of HIV Interventions Among Women Drug UsersWomen & Health, 1998
- HIV Sex and Drug Risk Behavior and Behavior Change in a National Sample of Injection Drug and Crack Cocaine Using WomenWomen & Health, 1998
- Risk Behavior and HIV Seroincidence Among Out-of-Treatment Injection Drug Users: A Four-Year Prospective StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- HIV seroconversion in intravenous drug users in San Francisco, 1985–1990AIDS, 1994
- Household bleach as disinfectant for use by injecting drug usersThe Lancet, 1993
- Needle-Cleaning Practices among Intravenous Drug users who Share Injection Equipment in Baltimore, MarylandInternational Journal of the Addictions, 1992
- Transmission of the Human Immunodeficiency VirusNew England Journal of Medicine, 1987